EQS News EQS News
News
Feed
Events
Feed
News
+ Events
Feed

Recently viewed news

Recently viewed Companies

Search Results of news

Show all

Search Results of Companies

Show all

Search Results of events

Show all
News Feed My Watchlists News Latest Reports Latest Research My favorite News
Events Feed Past Events Upcoming Webcasts Past Webcasts My favorite Events
Log in/Register
en

Recently viewed news

Recently viewed Companies

Search Results of news

Show all

Search Results of Companies

Show all

Search Results of events

Show all
  • ISIN DE0005313704
  • Country Deutschland

Ad-hoc | 15 December 2023 17:43

Carl Zeiss Meditec AG
Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.

Carl Zeiss Meditec AG / Key word(s): Takeover/Mergers & Acquisitions
Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.

15-Dec-2023 / 17:43 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

 
Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
 
Jena, December 15, 2023

Carl Zeiss Meditec AG (ISIN: DE0005313704) announces today that it has entered into a definitive agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center (International) BV, Zuidland, Netherlands (D.O.R.C.), from the investment firm Eurazeo SE, Paris, France (ISIN: FR0000121121). D.O.R.C. is a leading company in the vitreo-retinal surgery segment with close to EUR 200 million in revenue expected in fiscal 2023 and an operating profit in the mid double digit million EUR range. The acquisition will enhance and compliment Carl Zeiss Meditec’s ophthalmic portfolio for addressing a wide variety of eye conditions, including retinal disorders, cataracts, glaucoma and refractive errors.

The acquisition is expected to close in the first half of calendar year 2024 subject to applicable regulatory and antitrust approvals. The transaction is valued at an enterprise value of approximately EUR 985 million. The purchase price will be paid for primarily by available net liquidity of Carl Zeiss Meditec AG. In order to maintain operational flexibility, the company plans to seek a shareholder loan from Carl Zeiss AG in the amount of EUR 400 million as part of the financing, with a duration of three years and market-standard conditions.

The acquisition should achieve a modest positive contribution (by a single digit percentage amount) to the earnings per share of Carl Zeiss Meditec AG in the first full year after closing.
 

Contact for investors and press

Sebastian Frericks

Head of Group Finance & Investor Relations

Carl Zeiss Meditec AG

Tel.: +49 3641 220-116

E-Mail: investors.meditec@zeiss.com

 

 

 

 

 

 

 

 

 



End of Inside Information

15-Dec-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: investors.meditec@zeiss.com
Internet: www.zeiss.de/meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1798059

 
End of Announcement EQS News Service

show this

Latest News

News Functions

Additional Functions

6 August 2024

07:00 Corporate

Carl Zeiss Meditec AG

Corporate

Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue

30 July 2024

09:00 Advance Financial Reports

Carl Zeiss Meditec AG

Advance Financial Reports

 

17 June 2024

10:09 Ad-hoc

Carl Zeiss Meditec AG

Ad-hoc

Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business

8 May 2024

06:26 Corporate

Carl Zeiss Meditec AG

Corporate

Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects

30 April 2024

10:40 Advance Financial Reports

Carl Zeiss Meditec AG

Advance Financial Reports

 
More News

Latest Reports

News Functions

Additional Functions

16 August 2024

Quarterly Report PDF

Carl Zeiss Meditec AG

Quarterly Report
PDF

Q3 statement / Q3 financial report 2023/2024

16 May 2024

Quarterly Report PDF

Carl Zeiss Meditec AG

Quarterly Report
PDF

Half-yearly financial report 2023/2024

13 February 2024

Quarterly Report PDF

Carl Zeiss Meditec AG

Quarterly Report
PDF

Q1 statement / Q1 financial report 2023/2024
More Reports

Upcoming Events

Event Functions

Additional Functions

11

Dec 24

Carl Zeiss Meditec AG

Publication annual financial report

Berlin, Germany

12

Feb 25

Carl Zeiss Meditec AG

Press Release – quarterly statement (call-date Q1)

Conference Call

26

Mar 25

Carl Zeiss Meditec AG

Annual General Meeting

Jena, Germany, virtual

14

May 25

Carl Zeiss Meditec AG

Publication half-yearly financial report

Conference Call

07

Aug 25

Carl Zeiss Meditec AG

Press Release – quarterly statement (call-date Q3)

Conference Call
More Events

Webcasts

Event Functions

Additional Functions

06

Aug 24

Carl Zeiss Meditec AG

Analyst Conference – 9M 2023/24 Results

Visit Website

08

May 24

Carl Zeiss Meditec AG

Analyst Conference – 6M 2023/24 Results

Visit Website

09

Feb 24

Carl Zeiss Meditec AG

Analyst Conference – 3M 2023/24 Results

Visit Website

15

Dec 23

Carl Zeiss Meditec AG

Analyst Conference – Acquisition of D.O.R.C BV

Visit Website

10

May 21

Carl Zeiss Meditec AG

Analyst Conference – HY 2021 Results

Visit Website
More Webcasts
Language (EN)
Legal Notice Data Protection